Mediscount | Best Online Pharmacy for Generic Drugs

Razumab 2.3mg Injection

Manufactured By Intas Pharmaceuticals Ltd

Composition Ranibizumab (2.3mg)

Rs 15300.00

MRP Rs 17000.00

(10% OFF)

Includes all taxes

Package SIZE

( 1 Injection in 1 vial )

Out Of Stock

100% Authentic
Products

Free
Shipping*

Products
Return Policy

Information about Razumab 2.3mg Injection

Description:

Uses / Indications:

Razumab 2.3mg Injection is used in the treatment of wet form of age-related macular degeneration, diabetic macular edema and macular oedema due to retinal vein occlusion.

Interactions / Warnings:

Pregnancy interaction:

Razumab 2.3mg Injection may be unsafe to use during pregnancy.Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

Expert advice:

Patients should not drive or use machines immediately after receiving ranibizumab intravitreal injection which may influence the driving ability or ability to operate machines. Consult your ophthalmologist immediately if the eye becomes red, sensitive to light, painful or develops a change in vision. Before taking ranibizumab, inform you doctor if you are pregnant, planning a pregnancy or breast-feeding.

Side Effects:

Conjunctival hemorrhage, Eye pain, Eye inflammation, Eye floaters, Increased intraocular pressure.

How to use:

Your doctor or nurse will give you this medicine. Kindly do not self administer.

How it works:

Razumab 2.3mg Injection is a monoclonal antibody, used to treat several eye diseases causing vision impairment. It works by stopping abnormal blood vessel growth and leakage in the eye(s) that occur due to excess human vascular endothelial growth factor A (VEGF-A), thereby preventing from vision loss.

Faq for medicine:

Is Razumab FDA approved? : Yes, Razumab is approved by the FDA|What is Razumab injection and how does it work? : Razumab injection belongs to a class of medications called vascular endothelial growth factor (VEGF) antagonists. Razumab is used for the treatment of conditions that affect vision such as exudative (wet) neovascular age-related macular degeneration (AMD), macular edema (swelling) following retinal vein occlusion and macular edema (swelling) due to diabetes. Razumab binds extracellular VEGF thereby stopping abnormal blood vessel growth and leakage in the eye(s) which may lead to vision loss in people with wet AMD.